Noden Pharma Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 20

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

  • Investments
  • 1

Noden Pharma General Information

Description

Manufacturer of specialty pharmaceuticals committed to providing medicines that enhance the lives of people around the world. The company focuses on acquiring prescription medicines across a broad range of therapeutic areas in international markets and offers medicines containing aliskiren, a direct renin inhibitor, providing medical solutions for the treatment of hypertension.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • D'Olier Chambers
  • 16A D'Olier Street
  • Dublin
  • Ireland
+353 (01)
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • D'Olier Chambers
  • 16A D'Olier Street
  • Dublin
  • Ireland
+353 (01)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Noden Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Noden Pharma‘s full profile, request access.

Request a free trial

Noden Pharma Patents

Noden Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20110165240-A1 Galenical formulations of organic compounds Active 22-Sep-2008
US-8613949-B2 Galenical formulations of organic compounds Inactive 22-Sep-2008
US-20100130749-A1 Methods Active 03-Apr-2007
US-8338620-B2 Methods for the production of c-8 lactam lactone compounds Inactive 03-Apr-2007
ES-2704979-T3 Galenic formulations of aliskiren and hydrochlorothiazide Active 23-Jun-2006 A61K9/2018
To view Noden Pharma’s complete patent history, request access »

Noden Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Noden Pharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Noden Pharma‘s full profile, request access.

Request a free trial

Noden Pharma Investments (1)

Noden Pharma’s most recent deal was a Corporate Asset Purchase with Novartis (Tekturna). The deal was made on 06-Jul-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Novartis (Tekturna) 06-Jul-2016 Corporate Asset Purchase Buildings and Property
To view Noden Pharma’s complete investments history, request access »

Noden Pharma FAQs

  • When was Noden Pharma founded?

    Noden Pharma was founded in 2016.

  • Where is Noden Pharma headquartered?

    Noden Pharma is headquartered in Dublin, Ireland.

  • What is the size of Noden Pharma?

    Noden Pharma has 20 total employees.

  • What industry is Noden Pharma in?

    Noden Pharma’s primary industry is Pharmaceuticals.

  • Is Noden Pharma a private or public company?

    Noden Pharma is a Private company.

  • What is Noden Pharma’s current revenue?

    The current revenue for Noden Pharma is .

  • Who are Noden Pharma’s investors?

    Metric Capital Partners, PDL BioPharma, Stanley Capital, and Umbra Capital Partners have invested in Noden Pharma.

  • When was Noden Pharma acquired?

    Noden Pharma was acquired on 11-Oct-2022.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process